Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

被引:406
|
作者
Obici, S
Feng, ZH
Arduini, A
Conti, R
Rossetti, L
机构
[1] Albert Einstein Coll Med, Ctr Diabet Res & Training, Dept Med, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Ctr Diabet Res & Training, Dept Mol Pharmacol, Bronx, NY 10461 USA
[3] Sigma Tau Pharmaceut Ind, Dept Endocrinol & Metab, I-00040 Pomezia, Italy
关键词
D O I
10.1038/nm873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme carnitine palmitoyltransferase-1 (CPT1) regulates long-chain fatty acid (LCFA) entry into mitochondria, where the LCFAs undergo beta-oxidation. To investigate the mechanism(s) by which central metabolism of lipids can modulate energy balance, we selectively reduced lipid oxidation in the hypothalamus. We decreased the activity of CPT1 by administering to rats a ribozyme-containing plasmid designed specifically to decrease the expression of this enzyme or by infusing pharmacological inhibitors of its activity into the third cerebral ventricle. Either genetic or biochemical inhibition of hypothalamic CPT1 activity was sufficient to substantially diminish food intake and endogenous glucose production. These results indicated that changes in the rate of lipid oxidation in selective hypothalamic neurons signaled nutrient availability to the hypothalamus, which in turn modulated the exogenous and endogenous inputs of nutrients into the circulation.
引用
收藏
页码:756 / 761
页数:6
相关论文
共 50 条
  • [1] Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production
    Silvana Obici
    Zhaohui Feng
    Arduino Arduini
    Roberto Conti
    Luciano Rossetti
    Nature Medicine, 2003, 9 : 756 - 761
  • [2] Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
    Kennedy, JA
    Unger, SA
    Horowitz, JD
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (02) : 273 - 280
  • [3] Important role of ventromedial hypothalamic carnitine palmitoyltransferase-1a in the control of food intake
    Gao, Su
    Serra, Dolors
    Keung, Wendy
    Hegardt, Fausto G.
    Lopaschuk, Gary D.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2013, 305 (03): : E336 - E347
  • [4] Phosphorylation of rat liver carnitine palmitoyltransferase-1
    Hoppel, C
    Kerner, J
    Distler, A
    Minkler, P
    FASEB JOURNAL, 2004, 18 (05): : A862 - A862
  • [5] Hypothalamic carnitine palmitoyltransferase 1 (CPT-1) regulates glucose production (GP)
    Pocai, A
    Morgan, K
    Arduini, A
    Obici, S
    Rossetti, L
    DIABETES, 2003, 52 : A68 - A68
  • [6] Phosphorylation of carnitine palmitoyltransferase-1 in heart mitochondria
    Sharma, Vijay
    Parsons, Hannah
    Allard, Michael F.
    McNeill, John H.
    FASEB JOURNAL, 2008, 22
  • [7] Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity
    Kuhajda, Francis P.
    Ronnett, Gabriele V.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (04) : 312 - 317
  • [8] Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176
    Hamdan, M
    Urien, S
    Le Louet, H
    Tillement, JP
    Morin, D
    PHARMACOLOGICAL RESEARCH, 2001, 44 (02) : 99 - 104
  • [9] Does carnitine deprivation alter expression of myocardial carnitine palmitoyltransferase-1?
    Penn, D
    Debata, C
    FASEB JOURNAL, 2003, 17 (04): : A699 - A699
  • [10] ELEVATED PLASMA CARNITINE IN THE HEPATIC FORM OF CARNITINE PALMITOYLTRANSFERASE-1 DEFICIENCY
    STANLEY, CA
    SUNARYO, F
    HALE, DE
    BONNEFONT, JP
    DEMAUGRE, F
    SAUDUBRAY, JM
    JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (05) : 785 - 789